http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S55133384-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01c1e0bc0628f76dea731cda5a666ca1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
filingDate 1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7d3979e29bc356efe90e03ff06edd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c6769f8defd4fc938e1522235776f29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65a39cd8425e6990e8aab9d9041cc911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b55b8f14d47fab45504f95b06c9b89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae3aa0ff7524c041811da4f6b8c30127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d3a10e23c077ef2dc703175bbf1ba4
publicationDate 1980-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S55133384-A
titleOfInvention Preparation of rifamycin derivative
abstract PURPOSE: To obtain the title compound useful as an intermediate for the synthesis of an antitubercular rifampicin readily in high yield, by reacting rifamycin S or SV with tert-butylazomethin in the presence of an oxidizing agent in chloroform. n CONSTITUTION: Rifamycin S or SV is reacted with tert-butylazomethin in the presence of an oxidizing agent, e.g. MnO 2 or PbO 2 , in chloroform at room temperature to the boiling point of the solvent, preferably 50W60°C, to give the compound of the formula. tert-Butylazomethine is obtained by reacting equimolar amounts of formalin with tert-butylamine. n EFFECT: The use of chloroform provides the objective substance in high yield without requiring an excess amine which has been essential. The product after the reaction is readily rinsed without replacing the solvent with another one. n COPYRIGHT: (C)1980,JPO&Japio
priorityDate 1979-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226742447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136122621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431847471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135925261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88315665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135900090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234023478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415777968

Total number of triples: 42.